Biltmore Family Office, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Biltmore Family Office, LLC

$678 Million
Q3 2025

A detailed history of Biltmore Family Office, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Biltmore Family Office, LLC holds 15,470 shares of XBI stock, worth $1.67 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

15,470

Previous 16,899 8.46%

Holding current value

$1.67 Million

Previous $1.4 Million 10.64%

% of portfolio

0.23%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$83.08 - $100.2 $118,721 - $143,185	-1,429 Reduced 8.46%	15,470 $1.55 Million
Q2 2025 Aug 01, 2025	SELL	$69.8 - $85.28 $36,714 - $44,857	-526 Reduced 3.02%	16,899 $1.4 Million
Q1 2025 May 12, 2025	SELL	$81.1 - $94.7 $59,608 - $69,604	-735 Reduced 4.05%	17,425 $1.41 Million
Q4 2024 Feb 12, 2025	SELL	$89.81 - $104.0 $89,450 - $103,584	-996 Reduced 5.2%	18,160 $1.64 Million
Q3 2024 Nov 12, 2024	BUY	$90.87 - $102.43 $91,687 - $103,351	1,009 Added 5.56%	19,156 $1.89 Million
Q2 2024 Aug 07, 2024	BUY	$82.22 - $94.12 $59,609 - $68,237	725 Added 4.16%	18,147 $1.68 Million
Q1 2024 May 14, 2024	BUY	$87.05 - $102.89 $214,230 - $253,212	2,461 Added 16.45%	17,422 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$64.12 - $90.86 $963,787 - $1.37 Million	-15,031 Reduced 50.12%	14,961 $1.34 Million
Q3 2023 Nov 14, 2023	BUY	$71.88 - $85.76 $140,166 - $167,232	1,950 Added 6.95%	29,992 $2.19 Million
Q2 2023 Aug 07, 2023	BUY	$75.38 - $90.23 $58,645 - $70,198	778 Added 2.85%	28,042 $2.33 Million
Q1 2023 May 12, 2023	SELL	$73.13 - $91.97 $308,389 - $387,837	-4,217 Reduced 13.4%	27,264 $2.08 Million
Q4 2022 Feb 07, 2023	BUY	$76.72 - $85.66 $325,753 - $363,712	4,246 Added 15.59%	31,481 $2.61 Million
Q3 2022 Nov 10, 2022	BUY	$75.06 - $94.9 $501,325 - $633,837	6,679 Added 32.49%	27,235 $2.16 Million
Q2 2022 Aug 04, 2022	SELL	$62.81 - $96.09 $457,319 - $699,631	-7,281 Reduced 26.16%	20,556 $1.53 Million
Q1 2022 May 12, 2022	SELL	$81.07 - $115.44 $1.01 Million - $1.44 Million	-12,477 Reduced 30.95%	27,837 $2.5 Million
Q4 2021 Feb 11, 2022	BUY	$108.77 - $134.15 $3.99 Million - $4.93 Million	36,722 Added 1022.33%	40,314 $4.51 Million
Q3 2021 Nov 12, 2021	SELL	$118.69 - $138.49 $49,849 - $58,165	-420 Reduced 10.47%	3,592 $452,000
Q2 2021 Jul 30, 2021	SELL	$122.48 - $139.69 $8,206 - $9,359	-67 Reduced 1.64%	4,012 $543,000
Q1 2021 May 12, 2021	BUY	$129.36 - $173.99 $20,309 - $27,316	157 Added 4.0%	4,079 $553,000
Q4 2020 Feb 09, 2021	BUY	$110.36 - $151.14 $50,986 - $69,826	462 Added 13.35%	3,922 $552,000
Q3 2020 Nov 12, 2020	SELL	$103.87 - $120.36 $39,158 - $45,375	-377 Reduced 9.83%	3,460 $386,000
Q2 2020 Aug 05, 2020	BUY	$73.26 - $114.17 $7,838 - $12,216	107 Added 2.87%	3,837 $430,000
Q1 2020 May 08, 2020	SELL	$65.95 - $98.35 $58,497 - $87,236	-887 Reduced 19.21%	3,730 $289,000
Q4 2019 Feb 05, 2020	SELL	$74.65 - $98.46 $3.58 Million - $4.72 Million	-47,929 Reduced 91.21%	4,617 $439,000
Q3 2019 Oct 16, 2019	SELL	$76.25 - $83.86 $17,918 - $19,707	-235 Reduced 0.45%	52,546 $4.01 Million
Q2 2019 Jul 31, 2019	BUY	N/A	5,615 Added 11.9%	52,781 $4.63 Million
Q1 2019 Apr 12, 2019	BUY	N/A	3,520 Added 8.06%	47,166 $4.27 Million
Q4 2018 Feb 13, 2019	BUY	N/A	12,419 Added 39.77%	43,646 $3.13 Million
Q3 2018 Oct 30, 2018	SELL	N/A	-55 Reduced 0.18%	31,227 $2.99 Million
Q2 2018 Jul 17, 2018	BUY	N/A	10,752 Added 52.37%	31,282 $2.98 Million
Q1 2018 May 15, 2018	BUY	N/A	20,530 New	20,530 $1.8 Million

Others Institutions Holding XBI

# of Institutions

819

Shares Held

111M

Call Options Held

22.6M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.

Account

Biltmore Family Office, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History